Seminars in Radiation Oncology

Papers
(The TQCC of Seminars in Radiation Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The Biological Process of Aging and the Impact of Ionizing Radiation50
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation48
Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy47
Advances and Challenges in Trials of Local Therapy for Patients With Oligometastatic or Oligoprogressive Disease37
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy28
Mature Experiences Using Local Therapy for Oligometastases24
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer24
The Use of MR-Guided Radiation Therapy for Liver Cancer23
Seminars in Radiation Oncology—Breast Cancer21
Particle Beam Therapy for Cardiac-Sparing Radiotherapy in Non-Small Cell Lung Cancer20
The Evolving Role of Hypofractionated Radiotherapy in Older Adults with Gastrointestinal Cancers20
Technical Giants But Biologic Infants: Defining a More Sophisticated Role for Local Therapy in Metastatic Disease19
Improving the Education of Radiation Oncology Professionals in Geriatric Oncology: Where Are We and Where Should We Be?19
The Quality Assurance of a 1.5 T MR-Linac17
Local Ablative Therapy in Oligometastatic NSCLC16
DCIS: Risk Assessment in the Molecular Era15
Global Workforce and Access: Demand, Education, Quality15
Oncometabolites as Regulators of DNA Damage Response and Repair15
The Future of Education in Radiation Oncology14
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management12
The Evolving Role of Whole Breast Hypofractionation in Older Patients With Early Breast Cancer12
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity12
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets11
Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-8311
Radiation Therapy in the Management of Adrenal Metastases11
The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies11
Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?11
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician11
Spatially Fractionated Radiotherapy in the Era of Immunotherapy11
The Role of Radiotherapy in Hematologic Malignancies in Children, Adolescents, and Young Adults10
Metastatic Head and Neck Cancer: Immunotherapy and Beyond10
Future of Multidisciplinary Team in the Context of Adaptive Therapy9
Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape9
Immunotherapy for HPV Malignancies9
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck9
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management8
The Future of Head and Neck Radiotherapy: Not Your Father's Three-Field8
Head and Neck Cancer of Unknown Primary: A Surgical Perspective8
Mechanisms of Immune Modulation by Radiation8
Principles and Paradigms of De-Escalated Elective Nodal Irradiation: Boldly Going Towards an Inflection Point in Head and Neck Radiotherapy8
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology8
Personalising Nasopharyngeal Cancer: Systemic Therapy and Radiotherapy Treatment Volumes8
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer7
Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence7
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations7
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology7
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care7
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC7
Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast6
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care6
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy6
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?6
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC6
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease6
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status6
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer6
Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches6
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription6
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions6
0.25139284133911